Our studies demonstrate that CD4+ T cells expanded against tumor antigen secrete high levels of CCL5, thus promoting the recruitment of CCR5 expressing T cells and DCs to the tumor site [24, 86]. The gene discussed is CCL5; the disease is neoplasm.